METTL3-Mediated m⁶A Modification of circGLIS3 Promotes Prostate Cancer Progression and Represents a Potential Target for ARSI Therapy

Candidate circRNA was determined through a comprehensive analysis of public datasets, prostate cancer cell lines, and tissue data. A series of cellular functional assays, including CCK-8, colony formation, wound healing, and transwell assays were performed.